A shadow economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Investigational Drug Acquiring Popularity Online
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Express Concerns
However, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users administering products of uncertain source.
Several experts stated the demand for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.
Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.
Service Reaction and Material Removal
According to TikTok, the platform has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Investigations also found groups with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.
Within minutes of entering one group, a seller posted contact information, where most purchases take place. The seller sent an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Item Details and Pricing
Inside these groups, messages show black plastic packages with postal service stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it regularly moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service linked the surge in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly significant health risks”.
